Name: Acetyldihydrocodeine
Type: Opioid analgesic
AKA: Acetylcodone
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
|
IV. History
Acetyldihydrocodeine, a semi-synthetic opioid, was developed in the 20th century. It is used for its analgesic properties and contributes to the broader field of opioid research.
|
V. Legal Information
Acetyldihydrocodeine, an opioid analgesic, is classified as a Schedule I controlled substance in the US, making it illegal. It has been banned in many countries due to its high potential for abuse. The UNODC monitors synthetic opioids, highlighting the need for international regulation to prevent misuse. Trends show increasing control measures to address the opioid crisis and ensure public safety.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
VI. Physical Effects
Acetyldihydrocodeine is a semi-synthetic opioid used for pain relief. It causes sedation and respiratory depression, acting as a downer. Short-term use is effective for pain management, but long-term use can lead to addiction, tolerance, and health issues. Overdose risks include fatal respiratory depression. Safe use requires strict dosing and medical supervision. Recent research focuses on its analgesic properties and compares its risks with other opioids. |
VII. Psychological Effects
Acetyldihydrocodeine, an opioid analgesic, provides euphoria, sedation, and pain relief. Immediate effects include mood elevation and cognitive impairment. Long-term use can lead to addiction, tolerance, and withdrawal symptoms. Chronic use is associated with mood disorders, cognitive decline, and high overdose risk. Recent research highlights its abuse potential and mental health risks similar to other opioids.
|
VIII. Culture
Acetyldihydrocodeine is a semi-synthetic opioid with historical use in pain management. It was developed in the mid-20th century and is noted for its role in treating moderate pain. Its cultural significance involves its use in medicine versus concerns about opioid addiction. Proponents value its effectiveness in pain relief, while opponents focus on its potential for misuse and addiction. Its use is primarily medicinal, reflecting broader issues in opioid treatment.
|